{
    "clinical_study": {
        "@rank": "20196", 
        "acronym": "ESMAA", 
        "arm_group": {
            "arm_group_label": "8645 asthmatic  patients", 
            "description": "Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained."
        }, 
        "brief_summary": {
            "textblock": "Descriptive study on the management of asthma in asthmatic Middle East adult population :\n      Algeria,Egypt, Irak,Iran, Jordan, Koweit, Lebanon, Qatar,Saudi,Tunisia, UAE"
        }, 
        "brief_title": "Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "Multicentric, transversal, descriptive, epidemiological study, conducted in a random sample\n      of general practitioner and medical specialist (Pulmonologist and/or allergologist) in the\n      public and the private sector."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Men and women, 18 years of age and older. Asthmatic since at least one year before\n        inclusion. Patient's informed consent obtained.\n\n        Exclusion Criteria:\n\n          -  Patient concurrently participating to another study. Patient with concomitant\n             pulmonary disease. Patient with psychiatric disorders. Patient consulting for an\n             asthma attack"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Asthmatic since at least one year before inclusion. Patient's informed consent obtained."
            }
        }, 
        "enrollment": {
            "#text": "8645", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02153411", 
            "org_study_id": "NIS-RME-XXX-2014/1", 
            "secondary_id": "NIS-RME-XXX-2014/1"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "Asthma control", 
        "lastchanged_date": "June 3, 2014", 
        "number_of_groups": "1", 
        "official_title": "Evaluation of aSthma Management in Middle EAst Adult Population", 
        "overall_contact": {
            "email": "karima.kadi@astrazeneca.com", 
            "last_name": "Karima KADI, Medical Director", 
            "phone": "00213 770 260 866"
        }, 
        "overall_contact_backup": {
            "email": "antoine.estephan@astrazeneca.com", 
            "last_name": "Antoine Estephan, MEA Medical Director", 
            "phone": "+971 561148038"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Algeria: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Daytime symptoms Limitation of activities Nocturnal symptoms / awakening Need for reliever /rescue treatment Lung function (PEF or FEV)", 
            "measure": "Asthma control", 
            "safety_issue": "No", 
            "time_frame": "Up to 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02153411"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "sex, age, BMI, educational level, occupation, comorbidities, smoking status, and social security coverage.", 
                "measure": "general and sociodemographic patient's characteristics", 
                "safety_issue": "No", 
                "time_frame": "up to 1 year"
            }, 
            {
                "description": "such as age, sex, BMI, smoking status, adherence to treatment, asthma history, comorbidity.", 
                "measure": "Identify predictive factors of asthma control,", 
                "safety_issue": "No", 
                "time_frame": "UP to 1 year"
            }, 
            {
                "description": "Asthma control test questionnaire : activities at work,breathless,asthma symptoms (wheezing, coughing, chest tightness, shortness of breath;use of rescue inhaler or taken a nebulizer treatment ,asthma assessment", 
                "measure": "asthma control level", 
                "safety_issue": "No", 
                "time_frame": "Up to 4 weeks"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2014"
    }
}